AIMS/HYPOTHESIS: Genome-wide association studies have recently identified novel type 2 diabetes susceptibility gene regions. We assessed the effects of six of these regions on insulin secretion as determined by a hyperglycaemic clamp. METHODS: Variants of the HHEX/IDE, CDKAL1, SLC30A8, IGF2BP2 and CDKN2A/CDKN2B genes were genotyped in a cohort of 146 participants with NGT and 126 with IGT from the Netherlands and Germany, who all underwent a hyperglycaemic clamp at 10 mmol/l glucose. RESULTS: Variants of CDKAL1 and IGF2BP2 were associated with reductions in first-phase insulin secretion (34% and 28%, respectively). The disposition index was also significantly reduced. For gene regions near HHEX/IDE, SLC30A8 and CDKN2A/CDKN2B we did not find significant associations with first-phase insulin secretion (7-18% difference between genotypes; all p > 0.3). None of the variants showed a significant effect on second-phase insulin secretion in our cohorts (2-8% difference between genotypes, all p > 0.3). Furthermore, the gene variants were not associated with the insulin sensitivity index. CONCLUSIONS: Variants of CDKAL1 and IGF2BP2 attenuate the first phase of glucose-stimulated insulin secretion but show no effect on the second phase of insulin secretion. Our results, based on hyperglycaemic clamps, provide further insight into the pathogenic mechanism behind the association of these gene variants with type 2 diabetes.
AIMS/HYPOTHESIS: Genome-wide association studies have recently identified novel type 2 diabetes susceptibility gene regions. We assessed the effects of six of these regions on insulin secretion as determined by a hyperglycaemic clamp. METHODS: Variants of the HHEX/IDE, CDKAL1, SLC30A8, IGF2BP2 and CDKN2A/CDKN2B genes were genotyped in a cohort of 146 participants with NGT and 126 with IGT from the Netherlands and Germany, who all underwent a hyperglycaemic clamp at 10 mmol/l glucose. RESULTS: Variants of CDKAL1 and IGF2BP2 were associated with reductions in first-phase insulin secretion (34% and 28%, respectively). The disposition index was also significantly reduced. For gene regions near HHEX/IDE, SLC30A8 and CDKN2A/CDKN2B we did not find significant associations with first-phase insulin secretion (7-18% difference between genotypes; all p > 0.3). None of the variants showed a significant effect on second-phase insulin secretion in our cohorts (2-8% difference between genotypes, all p > 0.3). Furthermore, the gene variants were not associated with the insulin sensitivity index. CONCLUSIONS: Variants of CDKAL1 and IGF2BP2 attenuate the first phase of glucose-stimulated insulin secretion but show no effect on the second phase of insulin secretion. Our results, based on hyperglycaemic clamps, provide further insight into the pathogenic mechanism behind the association of these gene variants with type 2 diabetes.
Authors: Leen M 't Hart; Andreas Fritsche; Ingrid Rietveld; Jacqueline M Dekker; Giel Nijpels; Fausto Machicao; Michael Stumvoll; Cornelia M van Duijn; Hans U Häring; Robert J Heine; J Antonie Maassen; Timon W van Haeften Journal: Diabetes Date: 2004-02 Impact factor: 9.461
Authors: Alena Stancáková; Jussi Pihlajamäki; Johanna Kuusisto; Norbert Stefan; Andreas Fritsche; Hans Häring; Francesco Andreozzi; Elena Succurro; Giorgio Sesti; Trine Welløv Boesgaard; Torben Hansen; Oluf Pedersen; Per Anders Jansson; Ann Hammarstedt; Ulf Smith; Markku Laakso Journal: J Clin Endocrinol Metab Date: 2008-02-19 Impact factor: 5.958
Authors: Otto Tschritter; Michael Stumvoll; Fausto Machicao; Martin Holzwarth; Melanie Weisser; Elke Maerker; Anna Teigeler; Hans Häring; Andreas Fritsche Journal: Diabetes Date: 2002-09 Impact factor: 9.461
Authors: Laura Pascoe; Andrea Tura; Sheila K Patel; Ibrahim M Ibrahim; Ele Ferrannini; Eleftheria Zeggini; Michael N Weedon; Andrea Mari; Andrew T Hattersley; Mark I McCarthy; Timothy M Frayling; Mark Walker Journal: Diabetes Date: 2007-09-05 Impact factor: 9.461
Authors: Valgerdur Steinthorsdottir; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Thorbjorg Jonsdottir; G Bragi Walters; Unnur Styrkarsdottir; Solveig Gretarsdottir; Valur Emilsson; Shyamali Ghosh; Adam Baker; Steinunn Snorradottir; Hjordis Bjarnason; Maggie C Y Ng; Torben Hansen; Yu Bagger; Robert L Wilensky; Muredach P Reilly; Adebowale Adeyemo; Yuanxiu Chen; Jie Zhou; Vilmundur Gudnason; Guanjie Chen; Hanxia Huang; Kerrie Lashley; Ayo Doumatey; Wing-Yee So; Ronald C Y Ma; Gitte Andersen; Knut Borch-Johnsen; Torben Jorgensen; Jana V van Vliet-Ostaptchouk; Marten H Hofker; Cisca Wijmenga; Claus Christiansen; Daniel J Rader; Charles Rotimi; Mark Gurney; Juliana C N Chan; Oluf Pedersen; Gunnar Sigurdsson; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson Journal: Nat Genet Date: 2007-04-26 Impact factor: 38.330
Authors: S A Schäfer; O Tschritter; F Machicao; C Thamer; N Stefan; B Gallwitz; J J Holst; J M Dekker; L M 't Hart; L M t'Hart; G Nijpels; T W van Haeften; H U Häring; A Fritsche Journal: Diabetologia Date: 2007-07-28 Impact factor: 10.122
Authors: Frank Schwede; Oleg G Chepurny; Melanie Kaufholz; Daniela Bertinetti; Colin A Leech; Over Cabrera; Yingmin Zhu; Fang Mei; Xiaodong Cheng; Jocelyn E Manning Fox; Patrick E MacDonald; Hans-G Genieser; Friedrich W Herberg; George G Holz Journal: Mol Endocrinol Date: 2015-06-10
Authors: S Rodriguez; G Eiriksdottir; T R Gaunt; T B Harris; L J Launer; V Gudnason; I N M Day Journal: Growth Horm IGF Res Date: 2010-08 Impact factor: 2.372
Authors: M O Goodarzi; X Guo; J Cui; M R Jones; T Haritunians; A H Xiang; Y-D I Chen; K D Taylor; T A Buchanan; W A Hsueh; L J Raffel; J I Rotter Journal: Diabetologia Date: 2013-03-14 Impact factor: 10.122
Authors: Annemarie M Simonis-Bik; Giel Nijpels; Timon W van Haeften; Jeanine J Houwing-Duistermaat; Dorret I Boomsma; Erwin Reiling; Els C van Hove; Michaela Diamant; Mark H H Kramer; Robert J Heine; J Antonie Maassen; P Eline Slagboom; Gonneke Willemsen; Jacqueline M Dekker; Elisabeth M Eekhoff; Eco J de Geus; Leen M 't Hart Journal: Diabetes Date: 2009-10-15 Impact factor: 9.461
Authors: Leen M 't Hart; Annemarie M Simonis-Bik; Giel Nijpels; Timon W van Haeften; Silke A Schäfer; Jeanine J Houwing-Duistermaat; Dorret I Boomsma; Marlous J Groenewoud; Erwin Reiling; Els C van Hove; Michaela Diamant; Mark H H Kramer; Robert J Heine; J Antonie Maassen; Kerstin Kirchhoff; Fausto Machicao; Hans-Ulrich Häring; P Eline Slagboom; Gonneke Willemsen; Elisabeth M Eekhoff; Eco J de Geus; Jacqueline M Dekker; Andreas Fritsche Journal: Diabetes Date: 2009-10-06 Impact factor: 9.461
Authors: Alena Stancáková; Teemu Kuulasmaa; Jussi Paananen; Anne U Jackson; Lori L Bonnycastle; Francis S Collins; Michael Boehnke; Johanna Kuusisto; Markku Laakso Journal: Diabetes Date: 2009-06-05 Impact factor: 9.461